Canada markets closed

Summit Hotel Properties, Inc. (INN-PF)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.76+0.31 (+1.68%)
At close: 02:44PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close18.45
Open18.25
Bid18.75 x 800
Ask18.92 x 800
Day's Range18.25 - 18.85
52 Week Range17.11 - 27.02
Volume22,762
Avg. Volume5,640
Market CapN/A
Beta (5Y Monthly)2.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.47 (8.39%)
Ex-Dividend DateFeb 11, 2022
1y Target EstN/A
  • Newsfile

    Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: "It Was as If a New Dog Came into Our Lives"

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of Goody, an 8-year-old male mixed-breed dog, who was rescued in a terrible condition after he was found tied up with a very short leash, cachectic and wounded, was published. Goody suffers from ...

  • Newsfile

    Innocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy" on June 12, 2022, claiming priority from a US provisional patent. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can ...

  • Newsfile

    Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs

    Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 10, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the successful preliminary results of a small-scale efficacy trial in dogs with refractory (drug-resistant) epilepsy. In this initial phase, the dogs were treated with Innocan Pharma's LPT (CBD Loaded Liposome Platform) injection. The results demonstrate that these dogs had a decrease in the frequency of ...